1. Home
  2. BCAB vs SND Comparison

BCAB vs SND Comparison

Compare BCAB & SND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCAB
  • SND
  • Stock Information
  • Founded
  • BCAB 2007
  • SND 2011
  • Country
  • BCAB United States
  • SND United States
  • Employees
  • BCAB N/A
  • SND N/A
  • Industry
  • BCAB Medicinal Chemicals and Botanical Products
  • SND Mining & Quarrying of Nonmetallic Minerals (No Fuels)
  • Sector
  • BCAB Health Care
  • SND Industrials
  • Exchange
  • BCAB Nasdaq
  • SND Nasdaq
  • Market Cap
  • BCAB 22.3M
  • SND 91.3M
  • IPO Year
  • BCAB 2020
  • SND 2016
  • Fundamental
  • Price
  • BCAB $0.38
  • SND $1.97
  • Analyst Decision
  • BCAB Buy
  • SND Hold
  • Analyst Count
  • BCAB 2
  • SND 1
  • Target Price
  • BCAB $1.00
  • SND $2.25
  • AVG Volume (30 Days)
  • BCAB 507.7K
  • SND 102.6K
  • Earning Date
  • BCAB 08-07-2025
  • SND 08-12-2025
  • Dividend Yield
  • BCAB N/A
  • SND 5.08%
  • EPS Growth
  • BCAB N/A
  • SND N/A
  • EPS
  • BCAB N/A
  • SND N/A
  • Revenue
  • BCAB $11,000,000.00
  • SND $293,878,000.00
  • Revenue This Year
  • BCAB N/A
  • SND N/A
  • Revenue Next Year
  • BCAB N/A
  • SND N/A
  • P/E Ratio
  • BCAB N/A
  • SND N/A
  • Revenue Growth
  • BCAB N/A
  • SND N/A
  • 52 Week Low
  • BCAB $0.24
  • SND $1.73
  • 52 Week High
  • BCAB $2.53
  • SND $2.80
  • Technical
  • Relative Strength Index (RSI)
  • BCAB 42.24
  • SND 45.29
  • Support Level
  • BCAB $0.36
  • SND $2.00
  • Resistance Level
  • BCAB $0.43
  • SND $2.05
  • Average True Range (ATR)
  • BCAB 0.04
  • SND 0.08
  • MACD
  • BCAB -0.00
  • SND -0.01
  • Stochastic Oscillator
  • BCAB 16.00
  • SND 7.02

About BCAB BioAtla Inc.

BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise mecbotamab vedotin (BA3011), ozuriftamab vedotin (BA3021), and evalstotug (BA3071), and its Phase 1 clinical trial of BA3182 (CAB-EpCAM x CAB-CD3) and Bispecific antibody programs.

About SND Smart Sand Inc.

Smart Sand Inc. is a fully integrated frac sand company providing mine-to-well site proppant supply and logistics. It produces Northern White frac sand for enhanced hydrocarbon recovery in oil and gas wells. The company offers products like Smart System, SmartBelt, SmartDepot Silo, and SmartPath Loader. It is expanding into industrial markets, including glass, ceramics, and renewable energy, while its main revenue comes from sand sales and logistics.

Share on Social Networks: